Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation

Por van Luijn, Marvin M., Chamuleau, Martine E.D., Ossenkoppele, Gert J., van de Loosdrecht, Arjan A., Marieke van Ham, S.
Publicado em 2012

Class II–Associated Invariant Chain Peptide Expression Represents a Novel Parameter for Flow Cytometric Detection of Acute Promyelocytic Leukemia

Por van Luijn, Marvin M., Westers, Theresia M., Chamuleau, Martine E.D., van Ham, S. Marieke, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A.
Publicado em 2011

Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome

Por Chamuleau, Martine E.D., Westers, Theresia M., van Dreunen, Linda, Groenland, Judith, Zevenbergen, Adri, Eeltink, Corien M., Ossenkoppele, Gert J., van de Loosdrecht, Arjan A.
Publicado em 2009

Regulatory T cells and progenitor B cells are independent prognostic predictors in lower risk myelodysplastic syndromes

Por Kahn, Josephine D., Chamuleau, Martine E.D., Westers, Theresa M., Van de Ven, Peter M., van Dreunen, Linda, van Spronsen, Margot, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A.
Publicado no Haematologica (2015)

Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4(+) T-cell responses

Por van Luijn, Marvin M., Chamuleau, Martine E.D., Thompson, James A., Ostrand-Rosenberg, Suzanne, Westers, Theresia M., Souwer, Yuri, Ossenkoppele, Gert J., van Ham, S. Marieke, van de Loosdrecht, Arjan A.
Publicado em 2010

Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989–2010

Por Issa, Djamila E., van de Schans, Saskia A.M., Chamuleau, Martine E.D., Karim-Kos, Henrike E., Wondergem, Marielle, Huijgens, Peter C., Coebergh, Jan Willem W., Zweegman, Sonja, Visser, Otto
Publicado no Haematologica (2015)

Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes

Por van Luijn, Marvin M., Chamuleau, Martine E. D., Ressing, Maaike E., Wiertz, Emmanuel J., Ostrand-Rosenberg, Suzanne, Souwer, Yuri, Zevenbergen, Adri, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A., van Ham, S. Marieke
Publicado em 2010

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

Por Zinzani, Pier Luigi, Karlin, Lionel, Radford, John, Caballero, Dolores, Fields, Paul, Chamuleau, Martine E. D., d’Amore, Francesco, Haioun, Corinne, Thieblemont, Catherine, González-Barca, Eva, García, Carlos Grande, Johnson, Peter W., van Imhoff, Gustaaf W., Ng, Thomas, Dwyer, Karen, Morschhauser, Franck
Publicado no Haematologica (2016)